Jump Financial, LLC Biotechnology

Jump Financial, LLC

$4.56 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
URGN Uro Gen Pharma Ltd.	$270M	$716,000 0.02% of portfolio	56,450	Q3 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.23B	$694,000 0.02% of portfolio	34,941	Q3 2024 New
LRMR Larimar Therapeutics, Inc.	$344M	$619,000 0.01% of portfolio	94,651	Q3 2024 Added 107.35%
ADPT Adaptive Biotechnologies Corp	$797M	$614,000 0.01% of portfolio	120,020	Q3 2024 Added 38.22%
ARGX Argenx Se	$32.9B	$576,000 0.01% of portfolio	1,063	Q3 2024 Reduced 89.49%
VERV Verve Therapeutics, Inc.	$322M	$567,000 0.01% of portfolio	117,158	Q3 2024 Added 12.66%
VCEL Vericel Corp	$2.49B	$555,000 0.01% of portfolio	13,145	Q3 2024 New
EXEL Exelixis, Inc.	$11.3B	$549,000 0.01% of portfolio	21,159	Q3 2024 New
PRTA Prothena Corp Public LTD CO	$755M	$542,000 0.01% of portfolio	32,407	Q3 2024 Reduced 24.28%
DAWN Day One Biopharmaceuticals, Inc.	$1.05B	$529,000 0.01% of portfolio	38,010	Q3 2024 New
KYMR Kymera Therapeutics, Inc.	$2.51B	$524,000 0.01% of portfolio	11,091	Q3 2024 Reduced 52.84%
CABA Cabaletta Bio, Inc.	$115M	$518,000 0.01% of portfolio	109,786	Q3 2024 Reduced 39.72%
KURA Kura Oncology, Inc.	$1.1B	$487,000 0.01% of portfolio	24,940	Q3 2024 Reduced 34.49%
CGEM Cullinan Oncology, Inc.	$698M	$479,000 0.01% of portfolio	28,666	Q3 2024 Reduced 23.48%
CELC Celcuity Inc.	$211M	$445,000 0.01% of portfolio	29,872	Q3 2024 Added 55.58%
ITOS I Teos Therapeutics, Inc.	$301M	$410,000 0.01% of portfolio	40,182	Q3 2024 Added 55.84%
REPL Replimune Group, Inc.	$562M	$400,000 0.01% of portfolio	36,536	Q3 2024 Reduced 70.88%
IMTX Immatics N.V.	$650M	$383,000 0.01% of portfolio	33,600	Q3 2024 Reduced 31.42%
VNDA Vanda Pharmaceuticals Inc.	$288M	$362,000 0.01% of portfolio	77,213	Q3 2024 Reduced 40.82%
QURE Uni Qure N.V.	$315M	$355,000 0.01% of portfolio	72,152	Q3 2024 Reduced 3.82%
TERN Terns Pharmaceuticals, Inc.	$250M	$341,000 0.01% of portfolio	41,000	Q3 2024 New
LEGN Legend Biotech Corp	$6.68B	$331,000 0.01% of portfolio	6,800	Q3 2024 Reduced 85.27%
MRVI Maravai Lifesciences Holdings, Inc.	$684M	$312,000 0.01% of portfolio	37,617	Q3 2024 Reduced 22.45%
BCYC Bicycle Therapeutics PLC	$670M	$263,000 0.01% of portfolio	11,600	Q3 2024 Reduced 59.96%
VIR Vir Biotechnology, Inc.	$1.15B	$246,000 0.01% of portfolio	32,862	Q3 2024 Reduced 71.59%
NVO Novo Nordisk A S	$238B	$202,000 0.0% of portfolio	1,698	Q3 2024 New
ENTA Enanta Pharmaceuticals Inc	$210M	$170,000 0.0% of portfolio	16,400	Q3 2024 Added 7.89%
RZLT Rezolute, Inc.	$214M	$130,000 0.0% of portfolio	27,000	Q3 2024 New
SAGE Sage Therapeutics, Inc.	$319M	$128,000 0.0% of portfolio	17,802	Q3 2024 Added 31.53%
ZNTL Zentalis Pharmaceuticals, Inc.	$225M	$123,000 0.0% of portfolio	33,557	Q3 2024 New
NUVB Nuvation Bio Inc.	$623M	$77,000 0.0% of portfolio	33,673	Q3 2024 New
VYGR Voyager Therapeutics, Inc.	$240M	$64,000 0.0% of portfolio	10,999	Q3 2024 New
DSGN Design Therapeutics, Inc.	$336M	$59,000 0.0% of portfolio	11,000	Q3 2024 Reduced 45.24%
ABOS Acumen Pharmaceuticals, Inc.	$106M	$52,000 0.0% of portfolio	21,200	Q3 2024 Reduced 57.06%
ACIU Ac Immune Sa	$296M	$45,000 0.0% of portfolio	12,000	Q3 2024 Reduced 70.96%
VIGL Vigil Neuroscience, Inc.	$90.5M	$34,000 0.0% of portfolio	10,000	Q3 2024 New
PRLD Prelude Therapeutics Inc	$37.5M	$32,000 0.0% of portfolio	15,534	Q3 2024 New
AMRN Amarin Corp Plcuk	$210M	$6,000 0.0% of portfolio	10,909	Q3 2024 New
BCLI Brainstorm Cell Therapeutics Inc.	$39.4M	$2,000 0.0% of portfolio	10,995	Q3 2024 New
GLYC Glycomimetics Inc	$20.4M	$1,000 0.0% of portfolio	11,506	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.